1. Reversible metronidazole-induced encephalopathy
- Author
-
Rim Sebai, S. Nagi, Cyrine Drissi, M. Araar, Nadia Hammami, Y. Maatallah, M. Ben Hamouda, L. Belghith, and Fayçal Hentati
- Subjects
Gadolinium DTPA ,Male ,Brain Diseases ,Radiological and Ultrasound Technology ,medicine.diagnostic_test ,business.industry ,Resolution (electron density) ,Encephalopathy ,Contrast Media ,Magnetic resonance imaging ,Middle Aged ,medicine.disease ,Magnetic Resonance Imaging ,Metronidazole ,Nuclear magnetic resonance ,Anti-Infective Agents ,Neuroimaging ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Neurology (clinical) ,business ,Nuclear medicine ,medicine.drug - Abstract
We report the neuroimaging findings of a case of reversible metronidazole-induced encephalopathy. Magnetic resonance imaging (MRI) demonstrated lesions in highly suggestive locations. Follow-up imaging performed 1 month after cessation of metronidazole therapy demonstrated resolution of imaging findings.
- Published
- 2007